OnKure Therapeutics, Inc. shares held by Coastlands Capital LP
- Coastlands Capital LP filed a Schedule 13G on 2026-10-07.
- Holds 2,700,000 shares of Class A Common Stock.
- Represents 6.67% of the outstanding shares.
Coastlands Capital LP, filed by
Every EDGAR filing for OnKure Therapeutics, Inc. (OKUR), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 16)
No open-market insider buys in the last 30 days.
Also: 2 open-market sales ($1K).
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Coastlands Capital LP, filed by
Nicholas A Saccomano, insider filing for OKUR
Nicholas A Saccomano, reporting
Ownership stake disclosure by ADAR1 Capital Management, LLC (amended)
ADAR1 Capital Management, LLC, filed by
Isaac Manke, insider filing for OKUR (amended)
Isaac Manke, reporting
Edward T Mathers, insider filing for OKUR
Edward T Mathers, reporting
Ownership stake disclosure by Prosight Management, LP (amended)
Prosight Management, LP, filed by
Nicholas A Saccomano, insider filing for OKUR
Nicholas A Saccomano, reporting
Edward T Mathers, insider filing for OKUR
Edward T Mathers, reporting
Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND L P, filed by
Ownership stake disclosure by ADAR1 Capital Management, LLC (amended)
ADAR1 Capital Management, LLC, filed by
Len Blavatnik, new insider at OKUR
Len Blavatnik, reporting · Access Industries Holdings LLC, reporting · +2 more
Ownership stake disclosure by AI Biotechnology LLC
AI Biotechnology LLC, filed by
Ownership stake disclosure by StepStone Group LP
StepStone Group LP, filed by
Ownership stake disclosure by Trails Edge Capital Partners, LP
Trails Edge Capital Partners, LP, filed by
Nicholas A Saccomano, insider filing for OKUR
Nicholas A Saccomano, reporting